Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Neutropenia during HIV infection: adverse consequences and remedies.

Shi X, Sims MD, Hanna MM, Xie M, Gulick PG, Zheng YH, Basson MD, Zhang P.

Int Rev Immunol. 2014 Nov-Dec;33(6):511-36. doi: 10.3109/08830185.2014.893301. Epub 2014 Mar 21. Review.

2.

The changing role of HIV-associated oral candidiasis in the era of HAART.

Patuwo C, Young K, Lin M, Pardi V, Murata RM.

J Calif Dent Assoc. 2015 Feb;43(2):87-92. Review.

PMID:
25868223
3.

Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study.

Levine AM, Karim R, Mack W, Gravink DJ, Anastos K, Young M, Cohen M, Newman M, Augenbraun M, Gange S, Watts DH.

Arch Intern Med. 2006 Feb 27;166(4):405-10.

PMID:
16505259
4.

The prevalence of opportunistic infections and malignancies in autopsied patients with human immunodeficiency virus infection in Japan.

Katano H, Hishima T, Mochizuki M, Kodama Y, Oyaizu N, Ota Y, Mine S, Igari T, Ajisawa A, Teruya K, Tanuma J, Kikuchi Y, Uehira T, Shirasaka T, Koibuchi T, Iwamoto A, Oka S, Hasegawa H, Okada S, Yasuoka A.

BMC Infect Dis. 2014 Apr 29;14:229. doi: 10.1186/1471-2334-14-229.

5.

[Neutropenia in HIV infection].

Moreno García M.

An Med Interna. 1997 Apr;14(4):199-208. Review. Spanish.

PMID:
9181819
6.

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian.

PMID:
15305694
7.

Complications of HIV disease and antiretroviral therapy.

Havlir DV, Currier JS.

Top HIV Med. 2006 Mar-Apr;14(1):27-35.

8.

Deficient Phagocytosis Among HIV-1 Infected Adults Over Time Even in HAART Setting.

Tsachouridou O, Skoura L, Chatzidimitriou D, Margariti A, Georgiou A, Chatzidimitriou M, Bougiouklis D, Zebekakis P, Metallidis S.

Curr HIV Res. 2017;15(4):285-290. doi: 10.2174/1570162X15666170704101622.

PMID:
28675993
9.

Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.

Willemot P, Klein MB.

Expert Rev Anti Infect Ther. 2004 Aug;2(4):521-32. Review.

PMID:
15482218
10.

Etiology of neutropenia in HIV-infected patients.

Jaresko GS.

Am J Health Syst Pharm. 1999 Dec 15;56 Suppl 5:S5-8. Review.

PMID:
10613380
11.

Antiretroviral therapy and intestinal microsporidiosis in Thai HIV infected patients.

Wiwanitkit V.

Parasite. 2007 Sep;14(3):252. No abstract available.

12.

[Follow up of HIV-infected patients on antiretroviral treatment].

Chirouze C, Hoen B.

Rev Prat. 2006 May 15;56(9):966-75. Review. French.

PMID:
16775977
13.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.

N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.

14.

Prevention of opportunistic infections in the era of improved antiretroviral therapy.

Chaisson RE, Moore RD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16 Suppl 1:S14-22. Review.

PMID:
9389311
15.

Oral innate immunity in HIV infection in HAART era.

Nittayananta W, Tao R, Jiang L, Peng Y, Huang Y.

J Oral Pathol Med. 2016 Jan;45(1):3-8. doi: 10.1111/jop.12304. Epub 2015 Jan 31. Review.

16.

Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancy.

Sparano JA, Sarta C.

Curr Opin Oncol. 1996 Sep;8(5):392-9. Review.

PMID:
8914806
17.

AIDS: Part II.

Kessler HA, Bick JA, Pottage JC Jr, Benson CA.

Dis Mon. 1992 Oct;38(10):691-764. Review.

PMID:
1396036
18.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
19.

Management of human immunodeficiency virus in primary care.

Sell JK.

Prim Care. 2013 Sep;40(3):589-617. doi: 10.1016/j.pop.2013.05.002. Epub 2013 Jul 24. Review.

PMID:
23958359
20.

Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.

Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA.

J Oral Pathol Med. 2000 Aug;29(7):336-41.

PMID:
10947250

Supplemental Content

Support Center